Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0001209191-20-038910

President sold 50,000 shares at $75.00 ($3,750,000)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Novak Rodger President 2020-06-23 Sale −50,000 $75.00 $3,750,000 698,007 D: show line 1 in the form
Open-market sales · 50,000 sh · avg $75.00 · $3,750,000
Loading xslF345X03/doc4.xml…